Allworth Financial’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18K | Buy |
239
+122
| +104% | +$1.11K | ﹤0.01% | 3657 |
|
|
2025
Q1 | $912 | Sell |
117
-156
| -57% | -$1.22K | ﹤0.01% | 3490 |
|
|
2024
Q4 | $1.91K | Sell |
273
-42
| -13% | -$294 | ﹤0.01% | 3171 |
|
|
2024
Q3 | $2.28K | Buy |
315
+183
| +139% | +$1.32K | ﹤0.01% | 2908 |
|
|
2024
Q2 | $1.62K | Buy |
132
+3
| +2% | +$37 | ﹤0.01% | 3011 |
|
|
2024
Q1 | $2.42K | Buy |
129
+91
| +239% | +$1.71K | ﹤0.01% | 2742 |
|
|
2023
Q4 | $824 | Sell |
38
-720
| -95% | -$15.6K | ﹤0.01% | 3014 |
|
|
2023
Q3 | $15.6K | Buy |
758
+733
| +2,932% | +$15.1K | ﹤0.01% | 1674 |
|
|
2023
Q2 | $1.18K | Hold |
25
| – | – | ﹤0.01% | 2679 |
|
|
2023
Q1 | $1.05K | Buy |
25
+1
| +4% | +$42 | ﹤0.01% | 2653 |
|
|
2022
Q4 | $915 | Sell |
24
-25
| -51% | -$953 | ﹤0.01% | 2502 |
|
|
2022
Q3 | $2K | Buy |
49
+38
| +345% | +$1.55K | ﹤0.01% | 2212 |
|
|
2022
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 2754 |
|
|
2020
Q2 | – | Sell |
-4
| Closed | – | – | 1341 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1314 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1100 |
|
|
2019
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 910 |
|
|
2019
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 899 |
|
|
2019
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 914 |
|